Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Large-scale testing (Phase 3)Study completedNCT00469443What this trial is testingRandomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRCWho this might be right forColorectal Cancer Hellenic Oncology Research Group 330
Early research (Phase 1)Study completedNCT01846650What this trial is testingA Bioequivalence Study of Capecitabine TabletsWho this might be right forMetastatic Breast Cancer or Metastatic Colorectal Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT00637091What this trial is testingEfficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsWho this might be right forAdvanced Colorectal Cancer Asan Medical Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05731271What this trial is testingA First-in-Human, Phase 1 Study of TST003 in Subjects With Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic TumorColorectal Adenocarcinoma Transcenta Therapeutics (Hangzhou) Co., Ltd. 111
Not applicableStudy completedNCT01822444What this trial is testingANGIOPREDICT. ICORG 12-16, V3Who this might be right forAdvanced Colorectal Cancer Cancer Trials Ireland 76
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Early research (Phase 1)Study completedNCT03849469What this trial is testingXmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsWho this might be right forMelanomaCervical CarcinomaPancreatic Carcinoma+20 more Xencor, Inc. 78
Early research (Phase 1)Study completedNCT01183494What this trial is testingA Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsWho this might be right forMetastatic Colorectal Cancer University of Chicago 17
Early research (Phase 1)Study completedNCT00535353What this trial is testingAZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer NCIC Clinical Trials Group 26
Testing effectiveness (Phase 2)Ended earlyNCT00908024What this trial is testingCombination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerNeoplasm Metastasis Bristol-Myers Squibb 54
Testing effectiveness (Phase 2)Ended earlyNCT00320320What this trial is testingIrinotecan Discontinuation and Reintroduction for Advanced Colorectal CancerWho this might be right forColorectal NeoplasmsMetastases Gachon University Gil Medical Center 72
Early research (Phase 1)Looking for participantsNCT07094113What this trial is testingAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid TumorsWho this might be right forKRAS Altered Advanced or Metastatic Solid Tumors Amgen 434
Testing effectiveness (Phase 2)Looking for participantsNCT06760819What this trial is testingLearn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Solid TumorsHER2 Mutation Bayer 111
Early research (Phase 1)Ended earlyNCT05631574What this trial is testingStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerWho this might be right forNon Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more Biomea Fusion Inc. 13
Large-scale testing (Phase 3)Study completedNCT00975897What this trial is testingStudy of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal CancerWho this might be right forColorectal Cancer Medical Research Council 3,240
Early research (Phase 1)Study completedNCT00280176What this trial is testingBortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerWho this might be right forColorectal Cancer UNC Lineberger Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06553885What this trial is testingPh II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCCWho this might be right forMetastatic Colorectal CancerHepatocellular Carcinoma H. Lee Moffitt Cancer Center and Research Institute 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07814417What this trial is testingOlomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationWho this might be right forColorectal Neoplasms Eli Lilly and Company 50
Early research (Phase 1)Study completedNCT01607905What this trial is testingSafety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerWho this might be right forSolid Tumor Karyopharm Therapeutics Inc 192